瓦克预期2025年业务将实现增长
WACKER expects business growth in 2025

余凡    江西财经大学
时间:2025-04-05 语向:中-英 类型:化工 字数:630
  • 瓦克预期2025年业务将实现增长
    WACKER Expects Business Growth in 2025
  • 中化新网讯 3月15日,瓦克化学发布了2024财年报告,预计2025财年销售量将实现显著增长,尤其是化学业务部门的特种化学品和多晶硅业务。
    On March 15, Wacker Chemie released its 2024 fiscal year report. It is expected that the company will achieve significant growth in sales volume in the 2025 fiscal year, particularly in the specialty chemicals and polysilicon businesses within its chemical business division.
  • 报告显示,预计该年度销售额将在61亿至64亿欧元,各地区和各业务部门均可实现销售额增长;息税折旧摊销前利润(EBITDA)预期将在7亿至9亿欧元,EBITDA利润率将保持上年水平。资本支出预计将明显低于上年,略高于折旧和摊销,而折旧和摊销预计将略超5亿欧元。
    According to the report, the sales for that year are expected to range from 6.1 billion to 6.4 billion euros, and sales growth is anticipated to be achieved in all regions and business segments. The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) are expected to be between 0.7 billion and 0.9 billion euros, and the EBITDA margin will maintain the level of the previous year. The capital expenditure is expected to be significantly lower than that of the previous year, slightly higher than the depreciation and amortization expenses, which are projected to be slightly over 500 million euros.
  • 财报预计,2025年有机硅业务部门的销售额将增长约10%,主要原因是销售量增加,尤其是特种化学品的销售量;EBITDA利润率预期将略高于上年。聚合物业务部门的销售额预计将实现较低幅度的个位数百分点增长,乳液及可再分散乳胶粉业务的销售量预计将略有增长,但销售价格将略微下降;EBITDA利润率预期可保持上年水平。生物技术业务部门的销售额预计约为4亿欧元,但EBITDA利润率很有可能将略高于上年。多晶硅业务部门预期2025年可实现销售额10亿至13亿欧元,半导体级多晶硅的销售量预计增长显著,太阳能电池用的多晶硅业务则仍将继续面临挑战;EBITDA预期为1亿至2.5亿欧元。
    The financial report forecasts that the sales of the silicone business division in 2025 will increase by approximately 10%. This is mainly attributed to the growth in sales volume, particularly that of specialty chemicals. The EBITDA margin is anticipated to be slightly higher than that of the previous year.For the polymer business division, the sales are expected to experience a low single-digit percentage growth. In the emulsion and redispersible latex powder businesses, the sales volume is projected to rise slightly, yet the selling prices will decline marginally. The EBITDA margin is expected to remain at the level of the previous year.The sales of the biotechnology business division are estimated to be around 400 million euros, and there is a high likelihood that the EBITDA margin will be slightly higher than that of the previous year.Regarding the polysilicon business division, it is expected to achieve sales ranging from 1 billion to 1.3 billion euros in 2025. The sales volume of semiconductor-grade polysilicon is forecasted to increase significantly, while the polysilicon business for solar cells will still continue to encounter challenges. The EBITDA is expected to be between 100 million and 250 million euros.
  • 瓦克总裁兼首席执行官贺达对瓦克的中长期发展继续保持乐观。他表示:“瓦克的战略将保持不变。公司资金实力雄厚,并受益于全球各大趋势。无论是可再生能源、电动汽车,还是数字化,这些趋势都将继续推动公司的业务发展。今后的重点将更多地放在提高利润率上,而非销量增长。”
    Christian Hartel, President and CEO of Wacker Chemie, remains optimistic about Wacker's medium- to long-term development. He stated, "Wacker's strategy will stay unchanged. The company boasts a strong financial position and stands to benefit from major global trends. Be it renewable energy, electric vehicles, or digitalization, these trends will continue to propel the company's business forward. In the future, more emphasis will be placed on enhancing profit margins rather than on driving sales growth."

400所高校都在用的翻译教学平台

试译宝所属母公司